These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25161890)

  • 41. [The role of brain n-3 fatty acids-GPR40/FFAR1 signaling in pain].
    Nakamoto K; Tokuyama S
    Nihon Yakurigaku Zasshi; 2018; 151(1):21-26. PubMed ID: 29321392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.
    Tunaru S; Bonnavion R; Brandenburger I; Preussner J; Thomas D; Scholich K; Offermanns S
    Nat Commun; 2018 Jan; 9(1):177. PubMed ID: 29330456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
    Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
    Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.
    Li Z; Xu X; Huang W; Qian H
    Med Res Rev; 2018 Mar; 38(2):381-425. PubMed ID: 28328012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The HETE Is on FFAR1 and Pancreatic Islet Cells.
    Trauelsen M; Lückmann M; Frimurer TM; Schwartz TW
    Cell Metab; 2018 Feb; 27(2):273-275. PubMed ID: 29414682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiology and therapeutics of the free fatty acid receptor GPR40.
    Huang H; Dai MH; Tao YX
    Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders.
    Hara T; Hirasawa A; Ichimura A; Kimura I; Tsujimoto G
    J Pharm Sci; 2011 Sep; 100(9):3594-601. PubMed ID: 21618241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variants in the FFAR1 gene are associated with beta cell function.
    Kalis M; Levéen P; Lyssenko V; Almgren P; Groop L; Cilio CM
    PLoS One; 2007 Nov; 2(11):e1090. PubMed ID: 17987108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
    Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
    J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatty acid signaling in the beta-cell and insulin secretion.
    Nolan CJ; Madiraju MS; Delghingaro-Augusto V; Peyot ML; Prentki M
    Diabetes; 2006 Dec; 55 Suppl 2():S16-23. PubMed ID: 17130640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
    Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
    PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic β-cells.
    Marafie SK; Al-Shawaf EM; Abubaker J; Arefanian H
    Biol Res; 2019 Aug; 52(1):44. PubMed ID: 31426858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homology modeling and explicit membrane molecular dynamics simulation to delineate the mode of binding of thiazolidinediones into FFAR1 and the mechanism of receptor activation.
    Helal MA; Darwish KM; Hammad MA
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5330-6. PubMed ID: 25441945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism.
    Tomita T; Hosoda K; Fujikura J; Inagaki N; Nakao K
    Front Endocrinol (Lausanne); 2014; 5():152. PubMed ID: 25309513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma gene and strength athlete status.
    Maciejewska-Karlowska A; Sawczuk M; Cieszczyk P; Zarebska A; Sawczyn S
    PLoS One; 2013; 8(6):e67172. PubMed ID: 23799144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.